share_log

恒瑞医药关于子公司获得药物临床试验批准通知书的公告

Announcement of Jiangsu Hengrui Pharmaceuticals' Subsidiary Receiving Drug Clinical Trial Approval Notice

SZSI ·  Jun 4
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more